Tuesday, September 18, 2012

Medical Management of Comorbid BPH/LUTS and ED: Defining the Current Treatment Algorithm part 3


Which steps may improve treatment outcomes with PDE5 inhibitor therapy?
Patient education about correct use of the drug
Dose optimization
Psychosocial or psychosexual counseling to improve the couple's communication about sexual dysfunction and the patient's adherence to (and, thus, the efficacy of) ED treatment
All of the above




PDE5 inhibitors have helped to fill a void in the management of ED. Patients who do not initially respond to PDE5 inhibitor therapy may benefit from education about correct use, dose optimization (ie, titration, dosing schedule adjustment, and on-demand vs daily dosing), and treatment for comorbidities that may affect treatment response (eg, type 2 diabetes, hypertension, cardiovascular disease, depression, smoking, a sedentary lifestyle, and BPH and its treatment). Some men also benefit from psychosocial counseling to improve the couple's communication about sexual dysfunction and the patient's adherence to treatment.

Reply:

0 Comments:

Post a Comment

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Bluehost Review